2020 ACA San Diego Program Book_Winter Conference

C-1C Cultivating Collaboration Between State Government and Private Providers: The Indiana SOMM Model (CE) Room 9 This workshop will provide the

C-1D The Disease Model of Addiction: Medication Assisted Treatment and Related Clinical Therapies (CE, Y CE, CME, CERP) Room 11B The increasing abuse of opioids has created a health care crisis for correction’s facilities. Overdoses and increasing death from overdose are becoming all too common. The Disease Model of Addiction has shown the need for Medicated Assisted

attendee with detailed information relating to the real-world practices and experiences of the Indiana Sex Offender Management and Monitoring (INSOMM) Program, and the collaborative approach between the Indiana DOC and Liberty Behavioral Health Corporation that makes the program a success. An approach that focuses on maximizing positive outcomes by utilizing the strengths of each agency, state and private, is highlighted. Issues related to clearly understanding respective roles, managing boundaries, effective communication, sharing responsibility for success as well as problems, and other dynamics that occur in this type of partnership are also addressed. Learning Objectives: • Identify the challenges that commonly exist in relationships between state government and private providers in managing and treating sexual offenders in the community. • Learn specific strategies for maximizing identifying and utilizing the strengths and abilities of both private and public entities in the collaboration process. • Learn strategies for promoting better understanding of roles and boundaries, increasing and enhancing communication, and managing problems that arise in the process of collaboration between government and private agencies. Moderator: Adam Deming , Executive Director, INSOMM Program, Indianapolis, Indiana Speakers: Tracy Berry , B.A., M.A., Indiana DOC, Indianapolis, Indiana; Adam Deming , Psy.D., Liberty Behavioral Health Corporation, Indianapolis, Indiana positive treatment and management outcomes with sexual offenders by

Workshops

Monday, Jan. 13 t 2–3:30 p.m.

Treatments (MAT) to break the Cycle of Addiction and improve quality of life. MAT is seen as one important tool in combatting addiction along with Substance Use Disorder treatments and adjunct supports. This panel will illustrate and discuss the Disease Model in depth and the need to address triggers and urges of the brain disease. Narcan use to save lives and potential vicarious trauma will be discussed. This presentation will highlight the emerging threats of specific opioids and which states are most dramatically impacted. Models will be discussed along with DSM5 criteria for Substance Use Disorders. The panel will discuss tri-occurring Disorders and the complexity of overlapping disorders in a high-risk population. Brain functioning will be discussed with the promising findings of MAT as a standard of care, specifically outlining the pro/cons of use of Methadone and Naltrexone (Vivitrol). Also, to be discussed will be Substance Use Disorder Treatment and adjunct supports in addressing core psychological triggers for use. Sober supports networks and key changes in lifestyle are necessary to support recovery. The Disease Model of Addiction will be viewed from the lens of Behavioral, Biological and Social Context of Recovery. Learning Objectives: • Participants will understand the Disease Model of Addiction and its Behavioral, Biological and Social contexts. • Participants will learn Standards of Care for Suboxone and Naltrexone (Vivitrol) in the treatment of Opioid Addiction.

ACA 2020 Winter Conference — 115